Integral cell-biology platform for the development of the first effective treatment of radiodermatitis.

Project Information

SkinXCare

Grant agreement ID: 743887

DOI 10.3030/743887

Project closed

EC signature date 20 November 2016

Start date 1 December 2016

End date 31 March 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

INNOVATIVEHEALTH GROUP SL
Spain